Good post, Catkin.
Oh, there are some biotech and tech plays that show lots of possible upside. One of my picks, Mei Pharma (MEIP), has just rebounded off an oversold bottom and is now up 26% in past two weeks for me (on a cost-basis of $3.86) --presently in $4.80s with some respected analysts touting $10-$16 PTs.
That's just one that would be a good buy on any dip (if it dips much from here)....
I also like (and recently bought) Perma-Fix (PESI), which does nuclear waste cleanup and various services for the govt; trading around $4.30s now, it should be about $8 later this year just on its govt contract work --it's a big turnaround story after the govt sequester/shutdown slashed revenues for PESI and other contractors in 2013-14. Contracts are being awarded once again...
PESI's really major "blue sky" potential, though, is in its new medical isotopes division, which could realistically make it a $30-$100 stock within 15-30 months. There's a good S.Alpha article on that segment from a woman CFA and also some discussion by several shareholders at SSKILLZ' Value Microcaps board here on IHUB. It's just a matter of time before institutional and retail investors return to the PESI story, especially when their medical isotopes segment garners more attention.
Okay, this post is already "Off Topic," but you get the idea of things i'm looking at-- biotech and tech plays....
Market Data 
Markets 
AI
